FindTrial
Sign In

Developing a Patient-Centered Tool to Report Cancer Treatment Side Effects

Development of the Cancer Patient-reported Symptomatic Adverse Events Inventory (EORTC-PROAE) Using the EORTC Item Library: qualitative interview study - EORTC-PROAE

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/04/084517
Enrollment
135
Registered
2025-04-09
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

Intervention1: Nil: Nil

Sponsors

European Organisation for Research and Treatment of Cancer
Lead Sponsor
Tata Memorial Centre
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed with any type of cancer. Receiving any treatment for cancer; chemotherapy, radiotherapy, immunotherapy, targeted therapy with curative or palliative intent for cancer at the study site. consenting to participate

Exclusion criteria

Exclusion criteria: Poor command of the English/hindi/marathi/bangla language Unable to perform an interview due to cognitive or communication impairments

Design outcomes

Primary

MeasureTime frame
To develop new items, drawing on module development guidelines, for the missing AEs from the EORTC-IL. These are: hiccups, wheezing, acne, stretch marks, ringing in ears, missed expected menstrual period, change in usual urine colour, decreased sweating, and body odour.Timepoint: Not applicable for the study—

Secondary

MeasureTime frame
NoneTimepoint: NA—

Countries

Australia, Belgium, Croatia, Denmark, India, United Kingdom

Contacts

Public ContactRahul Krishnatry

Tata Memorial Centre

krishnatry@gmail.com02224177028

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026